Canada’s COVID-19 Immunity Task Force funds national study looking at seroprevalence of COVID-19 antibodies among high-risk populations
The Government of Canada is investing $1.9 million through Canada’s COVID-19 Immunity Task Force (CITF) to fund a Canadian Partnership for Tomorrow’s Health (CanPath) study looking at COVID-19 seroprevalence across Canada, with a particular focus on certain populations that are at higher risk of infection. CanPath is a national population health research platform that follows the health of 330,000 Canadians (or [...]